Esperion Therapeutics
ESPR
#6637
Rank
โ‚ฌ0.73 B
Marketcap
2,84ย โ‚ฌ
Share price
0.00%
Change (1 day)
35.01%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Last known market cap: โ‚ฌ0.73 Billion

As of November 2026 Esperion Therapeutics has a market cap of โ‚ฌ0.73 Billion. This makes Esperion Therapeutics the world's 6637th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ0.73 B-10.12%
2025โ‚ฌ0.81 B88.86%
2024โ‚ฌ0.43 B40.36%
2023โ‚ฌ0.30 B-28.13%
2022โ‚ฌ0.42 B59.16%
2021โ‚ฌ0.26 B-50.92%
2020โ‚ฌ0.54 B-62.57%
2019โ‚ฌ1.46 B35.7%
2018โ‚ฌ1.07 B-24.97%
2017โ‚ฌ1.43 B435.49%
2016โ‚ฌ0.26 B-41.44%
2015โ‚ฌ0.45 B-32.23%
2014โ‚ฌ0.67 B343.19%
2013โ‚ฌ0.15 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚ฌ155.55 B 21,127.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ85.42 B 11,557.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚ฌ1.41 B 93.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚ฌ0.56 B-22.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚ฌ4.06 B 455.22%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ10.12 B 1,282.12%๐Ÿ‡บ๐Ÿ‡ธ USA